BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $442,000 | +14.5% | 5,000 | 0.0% | 0.01% | +8.3% |
| Q3 2021 | $386,000 | -53.7% | 5,000 | -50.0% | 0.01% | -64.7% |
| Q2 2021 | $834,000 | -66.7% | 10,000 | -69.9% | 0.03% | -69.6% |
| Q1 2021 | $2,507,000 | -33.8% | 33,200 | +8.1% | 0.11% | -56.8% |
| Q2 2020 | $3,787,000 | – | 30,700 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maven Securities LTD | 10,000 | $834,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 241,100 | $20,117,000 | 0.02% |
| SIMPLEX TRADING, LLC | 94,500 | $7,885,000 | 0.01% |
| IMC-Chicago, LLC | 49,200 | $4,105,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 47,200 | $3,935,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |